However, it is unlikely that only the differences in growth rates in vitro translates to the robust tumor growth of the PTEN−/−KRAS(G12V) cells in vivo. In addition to growth promotion, activation of the PI3K and/or the Ras/MAPK pathway can result in increased cell survival. This evidence concerns the gene PIK3CA and neoplasm.